Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain received the 2025 Merkin Prize for developing CAR T-cell therapy — a personalized cancer immunotherapy that has treated more than 45,000 patients worldwide. Source: HPN Today newsletter archive.
Media Relations: Janet Janjigian — janjigianj@carmengroup.com